Twist Bioscience CEO Emily Leproust disposes of $8.77 million in common shares

• Twist Bioscience CEO Emily M. Leproust sold 46,391 common shares on Oct. 1-2.
• Sales priced at USD 200 and USD 188.884 per share.
• Directly held stake fell to 567,308 shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Twist Bioscience Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001214659-26-012551), on October 05, 2026, and is solely responsible for the information contained therein.